Creabilis Pulls In Corporate VC With €15M Series B
This article was originally published in The Pink Sheet Daily
Executive Summary
Abbott Biotech Ventures is the lead investor in a Series B fundraising for Creabilis to move its psoriasis candidate through Phase II.